Glucorine Nicotinamide Form Guide: 16 mg, NRV and Study Transfer
TL;DR:
- Start with the verified Glucorine label, daily serving and warning language.
- Use the three cited scientific sources as context; do not convert them into a finished-product medical claim.
- Keep suitability conditional on the complete formula, current label and individual professional guidance.
Glucorine's verified current label declares 16 mg of niacin in the recommended daily serving of two capsules and identifies nicotinamide as the source form. This guide asks a deliberately narrow question: what can the source name, label amount and reference percentage tell us, and what additional checks are required before human research can be transferred to the finished formula?
That question is different from a broad seven-active buyer guide. It keeps three layers separate: the declared nutrient and source form, the reference system used to express the amount, and the design of any proposed comparison study. Authorized energy-metabolism wording is retained later as secondary regulatory context; it is not the organizing thesis.
Commerce status is separate again. At the 2 September 2026 check, the canonical product page was live, but the mapped variant had zero inventory and storefront availability was false. Nothing below is a purchase invitation or stock promise.
Table of Contents
- Identify the Source Form
- Separate Source Form From Study Intervention
- Compare NRV With Dietary Reference Values
- Test Human Evidence for Transfer
- Keep Authorized Wording Secondary
- Retain the Formula and Warnings
- Use a Practical Transfer Check
Key Takeaways
| Question | Verified answer | Boundary |
|---|---|---|
| What is the source form? | Nicotinamide supplies the declared niacin line | A source name is not a clinical intervention |
| What is the label amount? | 16 mg per two capsules | It is not a personalized or proven-effective dose |
| Why does the panel say 100%? | 16 mg equals the fixed EU adult labeling NRV | NRV is not the same as an energy-adjusted dietary reference value |
| Can human studies transfer? | Only after form, amount, mixture, population, duration and endpoint are checked | Neither cited study tested Glucorine |
| Is the product purchasable? | The record and canonical page were active | The mapped variant was unavailable |
Identify the Source Form
The current Glucorine product information should be read alongside the primary regulatory label. The reporting unit is the complete recommended daily serving of two capsules. Within that unit, the panel names the nutrient as niacin, gives 16 mg as its amount and identifies nicotinamide as the source form. The same line reports 100% NRV.
| Label field | Declared value | What it establishes |
|---|---|---|
| Nutrient | Niacin | The nutrient category used for labeling |
| Source form | Nicotinamide | The form supplying that nutrient line |
| Daily amount | 16 mg | The amount in two capsules |
| Reference percentage | 100% NRV | The amount relative to the fixed EU labeling reference |
These four fields should not be collapsed into a claim about response. The label does not say that 16 mg is an effective study dose, that nicotinamide makes the product an NAD intervention, or that 100% predicts absorption or outcome. Each inference would require evidence beyond the composition panel.
The niacin line still belongs to a wider formula. The same serving declares 450 mg myo-inositol, 400 mg alpha-lipoic acid, 150 mg fenugreek seed extract, 10 mg zinc from zinc bisglycinate, 25 micrograms chromium from chromium picolinate and 5 mg black pepper fruit extract. That compact context prevents the ingredient-form analysis from being mistaken for a complete product evaluation.
Separate Source Form From Study Intervention
The EFSA scientific opinion on dietary reference values for niacin defines niacin as a generic term covering nicotinic acid and nicotinamide. This explains the label construction: “niacin” is the nutrient line, while “nicotinamide” identifies the contributing form.
That taxonomy does not make all niacin research interchangeable. A study may use nicotinic acid, nicotinamide, tryptophan or a mixture and may express exposure as niacin equivalents. Even when the same form name appears, the daily amount, delivery context, duration, population and endpoint can remain materially different.
Source-form matching is therefore a first screen, not a transfer decision. A paper that includes nicotinamide can inform general biological or methodological context, but it does not automatically test a 16 mg nicotinamide line inside a seven-active supplement. The finished product should not inherit an intervention's results simply because one ingredient name overlaps.
Compare NRV With Dietary Reference Values
Annex XIII of the current consolidated EU food-information regulation sets the adult niacin NRV at 16 mg. The Glucorine percentage is straightforward label arithmetic: 16 mg divided by the 16 mg reference equals 100%.
EFSA's dietary reference work uses a different frame. Because the body can form niacin from tryptophan, intake may be expressed as niacin equivalents; approximately 60 mg tryptophan corresponds to 1 mg niacin equivalent. For adults, EFSA derived an average requirement of 1.3 mg niacin equivalents per megajoule and a population reference intake of 1.6 mg per megajoule.
A fixed NRV makes labels comparable. An energy-adjusted dietary reference value addresses population dietary planning in relation to energy intake. A study intervention defines what researchers actually administered. The three numbers can appear in the same discussion, but they are not substitutes.
| Number type | Purpose | Do not infer |
|---|---|---|
| 16 mg EU NRV | Fixed adult reference for label percentages | A personal requirement, safety ceiling or outcome |
| EFSA mg NE/MJ values | Energy-adjusted dietary reference values | That every adult should use the same fixed intake |
| Research intervention amount | Exposure selected for a particular study design | A capsule target or finished-product dose |
This distinction is the central translation boundary. “100% NRV” is not 100% efficacy, and a research amount above or below 16 mg does not by itself validate or invalidate the Glucorine line. Purpose and design determine what each number means.
Test Human Evidence for Transfer
A controlled 80-day metabolic-feeding study in seven men supplied diets ranging from 6.1 to 32 niacin equivalents per day. Erythrocyte NAD fell by about 70% during the two low-intake periods and increased during repletion with an adequate diet, while NADP remained comparatively unchanged. This was a whole-diet status study, not a trial of a nicotinamide capsule, Glucorine or a subjective product outcome.
A later randomized double-blind controlled crossover trial in physically compromised older adults enrolled 14 people and completed the crossover analysis in 13. Each 32-day intervention period supplied 207.5 mg niacin equivalents through 210 mg L-tryptophan, 4 mg nicotinic acid and 200 mg nicotinamide. The nicotinamide component alone was twelve and a half times the 16 mg amount declared by Glucorine.
The higher-exposure trial increased skeletal-muscle methyl-nicotinamide, but it did not improve mitochondrial respiration, exercise efficiency or skeletal-muscle function, and skeletal-muscle NAD concentrations were not significantly different from control. That result belongs to its mixed precursor intervention, older physically compromised population, 32-day periods and measured endpoints. It cannot be converted into either a promise or a rejection of an individual response to Glucorine.
| Transfer check | Glucorine label | Cited human research |
|---|---|---|
| Exposure | 16 mg nicotinamide in two capsules | Whole diets or a 207.5 mg NE precursor mixture |
| Context | Seven-active finished formula | Controlled feeding or a mixed high-exposure intervention |
| Participants | No product trial population | Seven men or physically compromised older adults |
| Endpoints | No finished-product outcome established | Status markers, respiration, efficiency and muscle function |
The useful conclusion is methodological: shared terminology is not a shared intervention. Form, total niacin equivalents, co-ingredients, population, duration and endpoint must align before a result can transfer. Neither study tested the current Glucorine formula or establishes an effect from its 16 mg niacin entry.
Keep Authorized Wording Secondary
The European Commission's EU Register of Nutrition and Health Claims records the authorized wording that niacin “contributes to normal energy-yielding metabolism” when the conditions of use are met. It is relevant label context, but it does not answer the source-form or study-transfer questions.
- Contributes to describes a nutrient role, not a finished-formula result.
- Normal does not mean raising metabolism above normal or correcting a condition.
- Energy-yielding metabolism does not say the capsules supply calories, act as a stimulant or guarantee a felt effect.
The wording belongs to niacin and should not be extended to the entire ingredient blend. It must not be rewritten as “boosts energy,” “treats fatigue” or proof that 16 mg changes NAD. In this guide it remains a secondary boundary, not the headline or axis.
Retain the Formula and Warnings
The primary label controls the exact formula, serving and warnings. It lists HPMC for the capsule shell, silicon dioxide and magnesium salts of fatty acids as other ingredients. No named allergen or free-from declaration was identified, so silence cannot be converted into an allergen-free claim.
The label reserves use for adults, advises against use during pregnancy or breastfeeding and notes that the formula contains plant extracts. People taking medication are directed to consult a doctor or pharmacist. It also says not to exceed the recommended daily dose and explains that a supplement does not replace a varied, balanced diet and healthy lifestyle.
Keep the product out of reach of young children and store it dry at room temperature, protected from light and moisture. Those instructions remain relevant regardless of how a nutrient form or paper is discussed. Research comparison never overrides the label.
Availability also remains separate. The France record was ACTIVE and its canonical page returned HTTP 200 at the editorial check, but the mapped variant showed zero inventory, an inventory policy of deny and storefront availability false. ACTIVE described catalog status, not the ability to purchase.
Use a Practical Transfer Check
- Fix the serving: the 16 mg label amount belongs to two capsules.
- Name both levels: niacin is the nutrient; nicotinamide is its source form.
- Classify the reference: 100% uses the fixed 16 mg EU labeling NRV.
- Do not substitute systems: EFSA's energy-adjusted dietary references answer a different question.
- Reconstruct the intervention: identify total niacin equivalents, forms and co-ingredients.
- Match the design: compare population, duration and endpoint before discussing transfer.
- Retain product context: include the full formula, warnings and verified availability status.
The defensible conclusion is precise. Glucorine declares 16 mg niacin from nicotinamide per two capsules and expresses it as 100% of the fixed EU NRV. That source form and percentage do not make the product equivalent to a dietary-status study or a high-exposure mixed intervention. Human evidence becomes relevant only after a transparent transfer audit, while the complete formula, label warnings and current unavailability remain essential context.
Frequently Asked Questions
How much niacin does the Glucorine label declare, and in what form?
The verified label declares 16 mg of niacin per recommended daily serving of two capsules and identifies nicotinamide as its source form. It reports that amount as 100% of the EU nutrient reference value.
How does the fixed 16 mg NRV differ from EFSA dietary reference values?
The 16 mg EU NRV is a fixed adult labeling reference. EFSA instead derived adult dietary reference values per megajoule of energy intake and expresses intake as niacin equivalents. They answer different questions and should not be substituted for one another.
Does a shared nicotinamide name make a study directly applicable to Glucorine?
No. Source-form overlap is only one transfer check. Amount, total niacin equivalents, co-ingredients, population, duration and endpoint must also align before a study can inform a finished formula.
Did the cited human studies test 16 mg nicotinamide or Glucorine?
No. One study manipulated total dietary niacin equivalents, while the other used a 207.5 mg niacin-equivalent mixture containing tryptophan, nicotinic acid and 200 mg nicotinamide. Neither tested Glucorine, its 16 mg label amount or its seven-active formula.
Is Glucorine currently available to purchase?
At the 2 September 2026 check, Shopify classified the France product as ACTIVE and its canonical page returned HTTP 200. The mapped variant nevertheless had zero inventory, an inventory policy of deny and storefront availability false, so this guide makes no purchase or stock promise.
Recommended
- Glucorine Label Guide: 450 mg Myo-Inositol in a Seven-Active Formula
- Vitalux Men Zinc 15 mg: How to Read 150% NRV and Authorized Claims
- AndroWeight Vitamin B6 2 mg: An Authorized-Claim Reading Guide
- Review the current Glucorine product information
Our research and formulas have been recognized by leading media outlets such as Marie Claire.
Scientific References
- EFSA NDA Panel (2014): scientific opinion defining niacin as a generic term for nicotinic acid and nicotinamide and deriving energy-adjusted adult dietary reference values
- Fu et al. (1989): controlled 80-day metabolic-feeding study in seven men examining dietary niacin equivalents and erythrocyte markers
- Connell et al. (2021): randomized double-blind controlled crossover trial of a high-dose mixed NAD-precursor intervention in older adults
These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.
